Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
A population based study of the occurrence of scleroderma was carried out on the 4.1 million adult residents of the West Midlands Region. Seven separate sources were used to obtain cases. This first epidemiological study of scleroderma in the UK suggests prevalence rates of 13 and 48 per million in males and females respectively, with annual incidence rates of 1 and 6 per million. The peak age of onset is between 45 and 54 but new cases continue to arise even during the eighth decade. There is a pronounced female excess, with a ratio of 6:1, this excess being particularly marked in those under 45. It is difficult to assess the completeness of notification and thus the estimates should be considered as minimum. There are, however, suggestions in these data that the completeness of recording was high.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/rheumatology/27.4.286 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!